<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>WNT signals are transduced to the JNK pathway, the <z:chebi fb="0" ids="29108">Ca2+</z:chebi>-releasing pathway, or the beta-catenin - TCF pathway through seven-transmembrane-type WNT receptors encoded by Frizzled genes (FZD1-FZD10) </plain></SENT>
<SENT sid="1" pm="."><plain>WRCH1/ARHV and CDC42 are potentially implicated in the WNT-JNK pathway </plain></SENT>
<SENT sid="2" pm="."><plain>Here, WRCH2/ARHV cDNAs were isolated by using bioinformatics and cDNA-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>WRCH2 gene, consisting of at least 3 exons, encoded a 236-amino-acid protein with proline-rich domain and GTPase domain </plain></SENT>
<SENT sid="4" pm="."><plain>WRCH2 was homologous to WRCH1 (55.4% total-amino-acid identity) and CDC42 (43.5% total-amino-acid identity) </plain></SENT>
<SENT sid="5" pm="."><plain>WRCH2 gene was located on human chromosome 15q15, which is one of fragile sites in the human genome </plain></SENT>
<SENT sid="6" pm="."><plain>A single nucleotide substitution (632 Gright curved arrow A) was identified between WRCH2 cDNA and human genome draft sequences, which resulted in Arg177Lys amino-acid substitution </plain></SENT>
<SENT sid="7" pm="."><plain>WRCH2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was relatively highly expressed in pancreas, placenta, and fetal brain </plain></SENT>
<SENT sid="8" pm="."><plain>WRCH2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was over-expressed in TMK1 (<z:hpo ids='HP_0012126'>gastric cancer</z:hpo>), Hs700T (<z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo>), HeLa S3 (<z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e>), and A549 (<z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>) </plain></SENT>
<SENT sid="9" pm="."><plain>WRCH2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was moderately expressed in MKN74, MKN45, MKN28, KATO-III (<z:hpo ids='HP_0012126'>gastric cancer</z:hpo>), <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 (pro-myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>), Raji (Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>), and SW480 (<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>) </plain></SENT>
<SENT sid="10" pm="."><plain>WRCH2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was up-regulated in 3 out of 8 cases of primary <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Because Wrch1 can activate PAK1 and JNK1, and induce filopodium formation and stress fiber dissolution, over-expression of WRCH2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells might also lead to more malignant phenotype </plain></SENT>
</text></document>